MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells
Journal of Clinical Investigation · 01.04.2024 · 134 (7)
DOI: 10.1172/jci170848 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.01.2024. Verfasst von Rutger J Röring und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Radboud Center for Infectious Diseases and. Hauptthemen laut MEDLINE: Mumps, Rubella. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERC, Radboud University, Horizon2020; Marie Skłodowska-Curie grant.
Abstract (Originalsprache)
The measles, mumps, and rubella (MMR) vaccine protects against all-cause mortality in children, but the immunological mechanisms mediating these effects are poorly known. We systematically investigated whether MMR can induce long-term functional changes in innate immune cells, a process termed trained immunity, that could at least partially mediate this heterologous protection. In a randomized, placebo-controlled trial, 39 healthy adults received either the MMR vaccine or a placebo. Using single-cell RNA-Seq, we found that MMR caused transcriptomic changes in CD14 + monocytes and NK cells, but most profoundly in γδ T cells. Monocyte function was not altered by MMR vaccination. In contrast, the function of γδ T cells was markedly enhanced by MMR vaccination, with higher production of TNF and IFN-γ, as well as upregulation of cellular metabolic pathways. In conclusion, we describe a trained immunity program characterized by modulation of γδ T cell function induced by MMR vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Radboud Center for Infectious Diseases and.
- Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
- Department of Computational Biology for Individualised Medicine, Centre for Individualised Infection Medicine (CiiM) and.
- TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and Hannover Medical School (MHH), Hannover, Germany.
- Department of Immunology and Metabolism, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
- Department for Pediatric Oncology, Hematology and Clinical Immunology and.
Förderung
- ERC
- Radboud University
- Horizon2020; Marie Skłodowska-Curie grant
- Radboudumc
Zitieren
APA
Röring, R. J., Debisarun, P. A., Botey-Bataller, J., Suen, T. K., Bulut, Ö., Kilic, G., Koeken, V. A., Sarlea, A., Bahrar, H., Dijkstra, H., Lemmers, H., Gössling, K. L., Rüchel, N., Ostermann, P. N., Müller, L., Schaal, H., Adams, O., Borkhardt, A., Ariyurek, Y., …, & Netea, M. G. (2024). MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells. Journal of Clinical Investigation, 134(7). https://doi.org/10.1172/jci170848
Vancouver
Röring RJ, Debisarun PA, Botey-Bataller J, Suen TK, Bulut Ö, Kilic G, et al. MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells. Journal of Clinical Investigation. 2024;134(7). doi:10.1172/jci170848
BibTeX
@article{Rring2024,
author = {Röring, Rutger J and Debisarun, Priya A and Botey-Bataller, Javier and Suen, Tsz Kin and Bulut, Özlem and Kilic, Gizem and Koeken, Valerie Acm and Sarlea, Andrei and Bahrar, Harsh and Dijkstra, Helga and Lemmers, Heidi and Gössling, Katharina L and Rüchel, Nadine and Ostermann, Philipp N and Müller, Lisa and Schaal, Heiner and Adams, Ortwin and Borkhardt, Arndt and Ariyurek, Yavuz and de Meijer, Emile J and Kloet, Susan L and Ten Oever, Jaap and Placek, Katarzyna and Li, Yang and Netea, Mihai G},
title = {MMR vaccination induces trained immunity via functional and metabolic reprogramming of γδ T cells},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {7},
doi = {10.1172/jci170848}
}
EUVIMED